Literature DB >> 18619524

Harms and benefits of lymphocyte subpopulations in patients with acute stroke.

X Urra1, A Cervera, N Villamor, A M Planas, A Chamorro.   

Abstract

UNLABELLED: Lymphocytes are major players in the development of innate and adaptive immune responses but their behavior in patients with acute stroke has received little attention. EXPERIMENTAL PROCEDURES: Using flow cytometry we identified total lymphocytes, T cells, helper T (Th) cells, cytotoxic T lymphocytes (CTL), natural killer (NK) cells, B cells, and regulatory T (Treg) cells in 46 consecutive patients with acute stroke within a median of 180 min of clinical onset, and at days 2, 7, and 90. Daily neurological score (National Institutes of Health Stroke Scale), diffusion-weighted imaging on brain magnetic resonance imaging, functional impairment, and stroke-associated infection (SAI) at day 7 were assessed. Apoptosis in lymphocyte subsets, tumor necrosis factor (TNF) -alpha/interleukin (IL) -4 production in stimulated Th and CTL, cluster of differentiation 86 (CD86) (B7-2) expression in B cells, cortisol and metanephrine in serum were measured. Multivariate analyses were used to evaluate SAI, and stroke outcome.
RESULTS: Increased apoptosis and a fall of T, Th, CTL, B, and Treg cells were observed after stroke. Severer stroke on admission and SAI disclosed a greater decline of T, Th, and CTL cells. Increased cortisol and metanephrine was associated with severe stroke and SAI, and inversely correlated with T, and CTL. T cells, and CTL were correlated with infarct growth. Stroke but not SAI resulted in lower TNF-alpha production in Th cells. SAI showed the greatest fall of lymphocytes, T, Th, and CTL, but not B cells, or Treg. Poor outcome was associated with reduced levels of B cells, and increased expression of CD86 in B cells, but not with SAI.
CONCLUSION: Lymphopenia and increased apoptosis of T, Th, CTL, Treg and B cells are early signatures after human stroke. A decreased cellular response after stroke is a marker of ongoing brain damage, the stress response, and a higher risk of infection. A lower humoral response is predictor of poorer long-term outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619524     DOI: 10.1016/j.neuroscience.2008.06.014

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  76 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

Review 2.  Regulatory B cells in experimental stroke.

Authors:  Hilary A Seifert; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2018-02-05       Impact factor: 7.397

Review 3.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Regulatory T cells protect the brain after stroke.

Authors:  Anna M Planas; Angel Chamorro
Journal:  Nat Med       Date:  2009-02       Impact factor: 53.440

Review 5.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

6.  Neuroprotective and Anti-inflammatory Effects of a Dodecamer Peptide Harboring Ninjurin 1 Cell Adhesion Motif in the Postischemic Brain.

Authors:  Hye-Kyung Lee; Il-Doo Kim; Hahnbie Lee; Lidan Luo; Seung-Woo Kim; Ja-Kyeong Lee
Journal:  Mol Neurobiol       Date:  2017-11-14       Impact factor: 5.590

7.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

8.  Shifts in Leukocyte Counts Drive the Differential Expression of Transcriptional Stroke Biomarkers in Whole Blood.

Authors:  Grant C O'Connell; Madison B Treadway; Connie S Tennant; Noelle Lucke-Wold; Paul D Chantler; Taura L Barr
Journal:  Transl Stroke Res       Date:  2018-03-17       Impact factor: 6.829

9.  Usefulness of serum procalcitonin levels for the early diagnosis of stroke-associated respiratory tract infections.

Authors:  Andreas Hug; Bettina Mürle; Alexander Dalpke; Markus Zorn; Arthur Liesz; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

10.  Functional status of peripheral blood T-cells in ischemic stroke patients.

Authors:  Antje Vogelgesang; Verena E L May; Uwe Grunwald; Maren Bakkeboe; Soenke Langner; Henry Wallaschofski; Christof Kessler; Barbara M Bröker; Alexander Dressel
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.